W

Welcure Drugs and Pharmaceuticals Limited

WELCURE
Market snapshot · 2026-08-11 05:08 UTC

0.24

₹0.00 (+0.00%)

MARKET CAP

₹29.66 Cr

STOCK P/E

52W HIGH

₹1.18

52W LOW

₹0.22

BOOK VALUE

₹0.79

EPS

₹-0.04

ROE

-5.50%

SECTOR

Health Care

DEBT/EQUITY

VOLUME

12.15L

P/B RATIO

0.31x

PEG RATIO

Sector

Health Care

Themes

Pharmaceuticals
S
Split
₹1.08₹0.87₹0.66₹0.45₹0.24VolumeSAug '25Sep '25Nov '25Jan '26Mar '26Apr '26Jun '26Aug '26

AI Summary

✦ Clartha

Valuation Metrics

Forward Valuation Outlook

Forward outlook is unavailable because live next-12-month estimate data is not available for this ticker right now.

P/S
Strongly Undervalued

5Y Average

0.19

Current

0.08

Overvalued

0.22

Undervalued

0.16

P/B
Strongly Undervalued

5Y Average

0.61

Current

0.31

Overvalued

0.70

Undervalued

0.52

Peers & Comparison

No peer data available for this company.
WHY THESE PEERS

No sector data available for this company.

Financials

Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.

Latest revenue

₹0.00 CrMar 2026

Latest net profit

₹-50 CrMar 2026

Latest EPS

₹-0.40Mar 2026

Free cash flow

₹2.00 CrMar 2026

Performance

Bars show revenue and net profit. The line shows net margin.

Rs crore + margin %
Q4 '25Q1 '26Q2 '26Q3 '26Q4 '260.0%5.0%10.0%15.0%20.0%-100 Cr0.00 Cr100 Cr200 Cr300 Cr
  • Revenue
  • Net income
  • Net margin %

Earnings

Revenue is shown in crores. EPS is rupees per share.

Rs crore + Rs/share
Q4 '25Q1 '26Q2 '26Q3 '26Q4 '260.00 Cr75 Cr150 Cr225 Cr300 Cr₹-1₹0₹1₹1₹2
  • Revenue
  • EPS

Revenue to profit conversion

Bridge from operating numbers to profit for the latest reported period.

Rs crore
RevenueExpensesDepreciationOperatingprofitInterestProfitbefore taxTax & otherNet Profit-60 Cr-45 Cr-30 Cr-15 Cr0.00 Cr

Latest reported period: Mar 2026

Debt level and coverage

Debt, cash and free cash flow compared on the same crore scale.

Rs crore
Annual view
Mar 2025Sep 2025Mar 2026-250 Cr0.00 Cr250 Cr500 Cr750 Cr
  • Debt
  • Free cash flow
  • Cash & equivalents

Results

Sales

₹0 Cr

-100.0%

Net Profit

₹-50 Cr

-2062.4%

EBITDA

₹-50 Cr

-2057.7%

EPS

₹-0.40

-221.2%
MetricDec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales213006600
Expenses2126954050
Operating Profit13111-0-50
OPM %2.97%10.38%17.32%
Other Income21
Interest00000
Depreciation00000
Profit before tax331111-50
Tax %0.0%25.17%25.17%25.17%-0.0%
Net Profit32391-50
EPS in Rs0.332.070.070.13-0.40

All values in ₹ Crores unless otherwise stated. Source: Company filings.

Shareholding Pattern

HolderMar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Public98.99%98.74%91.82%94.41%95.62%
Others1.01%1.26%8.18%5.59%4.38%
Mar 2026
Public
Others